These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 297263)

  • 1. [Treatment of acute myeloid leukemia in the young and adult with aracytin and thioguanine].
    Gansl RC; Cabral E; Gomes Filho JM; Silveira PA; Gualandro SF; Zanichelli MA; Pozzi D
    Rev Hosp Clin Fac Med Sao Paulo; 1979; 34(5):207-10. PubMed ID: 297263
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of refractory acute leukemia with high-dose chemotherapy.
    Kramer BS; Appelbaum FR; Herzig GP; Graw RG; Levine AS
    Cancer Treat Rep; 1977 Oct; 61(7):1397-8. PubMed ID: 271045
    [No Abstract]   [Full Text] [Related]  

  • 4. [Difficulties of remission induction treatment of acute myeloblastic leukemia].
    Fière D; Bryon PA; Martin C; Revol L
    Sem Hop; 1974 May; 50(25):1691-4. PubMed ID: 4369538
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute myeloid leukaemia in adults with cytarabine and thioguanine].
    Fülle HH; Pribilla W
    Dtsch Med Wochenschr; 1972 May; 97(18):711-7. PubMed ID: 4502483
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of cytarabine and 6-thioguanine combination chemotherapy in acute leukemia].
    Drings P; Fritsch H; von Kaick G; Moskwa G; Sefrin R
    Verh Dtsch Ges Inn Med; 1973; 79():353-5. PubMed ID: 4524456
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences in the treatment of acute myeloblastic leukemia and acute monocytic leukemia using cytosine arabinoside and 6-thioguanine].
    Essers U; Althof S; Ewers M
    Verh Dtsch Ges Inn Med; 1975; 81():1126-8. PubMed ID: 1065154
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytarabine and thioguanine for acute nonlymphocytic leukemia. Another look.
    Saponara EJ; Rothenberg SP; Villamena D
    Arch Intern Med; 1979 Nov; 139(11):1277-80. PubMed ID: 292356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality of survival in patients with acute leukemia subjected to combination drug therapy].
    Almici C; Inzoli MR
    G Clin Med; 1976; 57(5-6):183-91. PubMed ID: 1070454
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of acute myeloid leukemia with an intense chemotherapeutic regimen and variable reduction of the dosage for elderly patients].
    Whittaker JA
    Clin Ter; 1982 Sep; 102(5):435-41. PubMed ID: 6960975
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
    [No Abstract]   [Full Text] [Related]  

  • 12. Two years' experience in the treatment of acute myeloid leukaemia using a three-drug regimen: daunorubicin, cytosine arabinoside and 6-thioguanine.
    McCann SR; Lawlor E; Kinsella IA; Temperley IJ
    Ir Med J; 1982 Nov; 75(11):415-7. PubMed ID: 6959984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of a clinical study of the preparation Lenvis in leukemias in children and adults].
    Kondrat'eva NA; Kruglova GV; Kovaleva LG; Makhonova LA; Volkova MA
    Probl Gematol Pereliv Krovi; 1981 Dec; 26(12):16-21. PubMed ID: 7036140
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
    Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D
    Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of acute myelogenous leukemia in adults; an account of the years 1968 to 1975].
    Willemze R; den Ottolander GJ; Heering KJ; Brand A; Zwaan FE; Haak HL; Hartgrink-Groeneveld CA; Jansen J; Eernisse JG
    Ned Tijdschr Geneeskd; 1977 Nov; 121(46):1843-7. PubMed ID: 270615
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of the influence of age on remission rate and duration of remission in a group of thirty-four patients with acute myeloid leukaemia.
    De Vries EG; Mulder NH; Houwen B; Haaxma-Reiche H; De Vries-Hospers HG
    Neth J Med; 1980; 23(6):241-5. PubMed ID: 6936611
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in acute myelogenous leukemia.
    Gale RP
    Cancer Treat Rep; 1981; 65 Suppl 4():87-92. PubMed ID: 7049383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute promyelocytic leukemia: confirmation of the therapeutic value of the cytosine arabinoside-thioguanine combination].
    Monica C; Cucinotta D; Carapezzi C; Ceccato S
    G Clin Med; 1976; 57(5-6):192-9. PubMed ID: 1070455
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute granulocytic leukemia: treatment of the disease.
    Weil M; Jacyuillat CI; Gemon-Auclerc MF; Chastang CL; Izrael V; Boiron M; Bernard J
    Arch Intern Med; 1976 Dec; 136(12):1389-95. PubMed ID: 1069571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.